Resmed (Australia) Insiders
RMD Stock | 38.59 0.48 1.26% |
Resmed employs about 21 people. The company is managed by 21 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Resmed's management performance can provide insight into the firm performance.
BE MBA CEO CEO Director |
AM AM Chairman Founder Chairman |
Resmed |
Resmed Management Team Effectiveness
The company has return on total asset (ROA) of 0.1327 % which means that it generated a profit of $0.1327 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2357 %, meaning that it generated $0.2357 on every $100 dollars invested by stockholders. Resmed's management efficiency ratios could be used to measure how well Resmed manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Resmed's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 7.2 B in 2024, whereas Change To Liabilities is likely to drop slightly above 24.6 M in 2024.Common Stock Shares Outstanding is likely to drop to about 140.2 M in 2024. Net Income Applicable To Common Shares is likely to drop to about 537.5 M in 2024
Resmed Workforce Comparison
Resmed Inc DRC is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 12,369. Resmed adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32. Resmed Inc DRC Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Resmed Inc DRC Price Series Summation is a cross summation of Resmed price series and its benchmark/peer.
Resmed Notable Stakeholders
A Resmed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Resmed often face trade-offs trying to please all of them. Resmed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Resmed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
AM BE | Chair Founder | Profile | |
BE MBA | CEO Director | Profile | |
AM AM | Founder Chairman | Profile | |
Constance Bienfait | Director Relations | Profile | |
Amy Wakeham | VP Communications | Profile | |
Justin Leong | Chief Officer | Profile | |
Michael Rider | Chief Secretary | Profile | |
Robert Douglas | Special Advisor | Profile | |
Vered Keisar | Chief Officer | Profile | |
Carlos MD | Chief Officer | Profile | |
Kaushik Ghoshal | Chief SaaS | Profile | |
YvonneKatrin Pucknat | Chief Officer | Profile | |
Michael Fliss | Chief Officer | Profile | |
Brett Sandercock | Chief Officer | Profile | |
David Pendarvis | Global Officer | Profile | |
Jim Ellis | Chief Officer | Profile | |
Alastair Robertson | Chief Officer | Profile | |
Hemanth Reddy | Chief Officer | Profile | |
Urvashi Tyagi | Chief Officer | Profile | |
Dawn Haake | Chief Officer | Profile | |
Todd Friedman | Chief Officer | Profile |
About Resmed Management Performance
The success or failure of an entity such as Resmed Inc DRC often depends on how effective the management is. Resmed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Resmed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Resmed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Resmed is entity of Australia. It is traded as Stock on AU exchange.
Please note, the imprecision that can be found in Resmed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Resmed Inc DRC. Check Resmed's Beneish M Score to see the likelihood of Resmed's management manipulating its earnings.
Resmed Workforce Analysis
Traditionally, organizations such as Resmed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Resmed within its industry.Resmed Manpower Efficiency
Return on Resmed Manpower
Revenue Per Employee | 223.1M | |
Revenue Per Executive | 223.1M | |
Net Income Per Employee | 48.6M | |
Net Income Per Executive | 48.6M | |
Working Capital Per Employee | 68.9M | |
Working Capital Per Executive | 68.9M |
Additional Tools for Resmed Stock Analysis
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.